{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:40:08Z","timestamp":1791589208089,"version":"4.3.4"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013609","name":"EEA Grants\/Norway Grants","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013609","name":"EEA Grants\/Norway Grants","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Antibiotic-resistant bacterial pathogens have become a serious threat worldwide. One of these pathogens is methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA), a major cause of skin and soft tissue infections. In this study we identified a strain of <jats:italic>Staphylococcus equorum<\/jats:italic> producing a substance with high antimicrobial activity against many Gram-positive bacteria, including MRSA. By mass spectrometry and whole genome sequencing the antimicrobial substance was identified as the thiopeptide bacteriocin micrococcin P1 (MP1). Based on its properties we developed a one-step purification protocol resulting in high yield (15 mg\/L) and high purity (98%) of MP1. For shorter incubation times (5-7\u00a0h) MP1 was very potent against MRSA but the inhibitory effect was overshadowed by resistance development during longer incubation time (24h or more). To overcome this problem a synergy study was performed with a number of commercially available antibiotics. Among the antibiotics tested, the combination of MP1 and rifampicin gave the best synergistic effect, with MIC values 25 and 60 times lower than for the individual drugs, respectively. To assess the therapeutic potential of the MP1-rifampicin combination, we used a murine skin infection model based on the use of the multidrug-resistant luciferase-tagged MRSA strain Xen31. As expected, neither of the single antimicrobials (MP1 or rifampicin) could eradicate Xen31 from the wounds. By contrary, the MP1-rifampicin combination was efficient not only to eradicate but also to prevent the recurrence of Xen31 infection. Furthermore, compared to fucidin cream, which is commonly used in skin infection treatments, MP1-rifampicin combination was superior in terms of preventing resistance development. Our results show that combining MP1, and probably other thiopeptides, with antibiotics can be a promising strategy to treat SSTIs caused by MRSA and likely many other Gram-positive bacteria.<\/jats:p>","DOI":"10.3389\/fimmu.2021.676534","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T15:29:14Z","timestamp":1625239754000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model"],"prefix":"10.3389","volume":"12","author":[{"given":"Kirill V.","family":"Ovchinnikov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kranjec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Telke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Kjos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tage","family":"Thorstensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzung B.","family":"Diep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"iii35","DOI":"10.1093\/jac\/dkq302","article-title":"Complicated Skin and Soft Tissue Infection","volume":"65","author":"Dryden","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00134-14","article-title":"Staphylococcus Aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/qco.0000000000000353","article-title":"The Role of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections","volume":"30","author":"Bassetti","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200725090-00004","article-title":"Epidemiology and Economic Impact of Meticillin-Resistant Staphylococcus Aureus: Review and Analysis of the Literature","volume":"25","author":"Shorr","year":"2007","journal-title":"PharmacoEconomics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1469-0691.12463","article-title":"European Perspective and Update on the Management of Complicated Skin and Soft Tissue Infections Due to Methicillin-Resistant Staphylococcus Aureus After More Than 10 Years of Experience With Linezolid","volume":"20","author":"Bassetti","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(01)05410-1","article-title":"Linezolid Resistance in a Clinical Isolate of Staphylococcus Aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet (Lond Engl)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.43.10.5285-5287.2005","article-title":"Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus Aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J Clin Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/aac.05004-14","article-title":"Ceftobiprole- and Ceftaroline-Resistant Methicillin-Resistant Staphylococcus Aureus","volume":"59","author":"Chan","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nmni.2017.05.009","article-title":"Identification of Tigecycline- and Vancomycin-Resistant Staphylococcus Aureus Strains Among Patients With Urinary Tract Infection in Iran","volume":"19","author":"Yousefi","year":"2017","journal-title":"New Microbes New Infect"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/aac.37.11.2432","article-title":"Teicoplanin-Resistant Staphylococcus Aureus Expresses a Novel Membrane Protein and Increases Expression of Penicillin-Binding Protein 2 Complex","volume":"37","author":"Shlaes","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-003-0966-7","article-title":"Characterisation of Methicillin-Resistant Staphylococcus Aureus With Reduced Susceptibility to Teicoplanin in Eastern France","volume":"22","author":"Bertrand","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuy033","article-title":"The Expanding Structural Variety Among Bacteriocins From Gram-Positive Bacteria","volume":"42","author":"Acedo","year":"2018","journal-title":"FEMS Microbiol Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1023\/a:1020582211262","article-title":"Production of Class II Bacteriocins by Lactic Acid Bacteria; An Example of Biological Warfare and Communication","volume":"81","author":"Eijsink","year":"2002","journal-title":"Antonie Van Leeuwenhoek"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2009.01.007","article-title":"Thiopeptide Biosynthesis Featuring Ribosomally Synthesized Precursor Peptides and Conserved Posttranslational Modifications","volume":"16","author":"Liao","year":"2009","journal-title":"Chem Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-019-02361-1","article-title":"Natural Thiopeptides as a Privileged Scaffold for Drug Discovery and Therapeutic Development","volume":"28","author":"Shen","year":"2019","journal-title":"Med Chem Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1006\/jmbi.1999.2600","article-title":"The Antibiotic Micrococcin Acts on Protein L11 at the Ribosomal GTPase Centre","volume":"287","author":"Porse","year":"1999","journal-title":"J Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.3.357","article-title":"The Antibiotics Micrococcin and Thiostrepton Interact Directly With 23S rRNA Nucleotides 1067A and 1095A","volume":"22","author":"Rosendahl","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1021\/cr0300441","article-title":"Thiopeptide Antibiotics","volume":"105","author":"Bagley","year":"2005","journal-title":"Chem Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005592","article-title":"Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells","volume":"4","author":"Bhat","year":"2009","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-06-1576","article-title":"Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1","volume":"66","author":"Radhakrishnan","year":"2006","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01096-10","article-title":"Thiostrepton and Derivatives Exhibit Antimalarial and Gametocytocidal Activity by Dually Targeting Parasite Proteasome and Apicoplast","volume":"55","author":"Aminake","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/md12010317","article-title":"Thiopeptide Antibiotics: Retrospective and Recent Advances","volume":"12","author":"Just-Baringo","year":"2014","journal-title":"Marine Drugs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tube.2016.07.011","article-title":"Micrococcin P1 -\u00a0A Bactericidal Thiopeptide Active Against Mycobacterium Tuberculosis","volume":"100","author":"Degiacomi","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-46304-4_31","article-title":"Micrococcin, an Antibacterial Substance Formed by a Strain of Micrococcus","volume":"29","author":"Su","year":"1948","journal-title":"Br J Exp Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/aem.66.6.2378-2384.2000","article-title":"The Macrocyclic Peptide Antibiotic Micrococcin P1 Is Secreted by the Food-Borne Bacterium Staphylococcus equorum WS 2733 and Inhibits Listeria Monocytogenes on Soft Cheese","volume":"66","author":"Carnio","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/aac.15.1.74","article-title":"Methicillin-Resistant Strains of Staphylococcus Aureus Phage Type 92","volume":"15","author":"Schaefler","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"B27","article-title":"Method for the Prevention and Treatment of Mastitis","author":"Suri","year":"2001","journal-title":"Google Patents"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/jb.173.12.3879-3887.1991","article-title":"Lactococcin A, A New Bacteriocin From Lactococcus Lactis subsp. Cremoris: Isolation and Characterization of the Protein and its Gene","volume":"173","author":"Holo","year":"1991","journal-title":"J Bacteriol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00248-012-0134-7","article-title":"Bacteriocin Production, Antibiotic Susceptibility and Prevalence of Haemolytic and Gelatinase Activity in Faecal Lactic Acid Bacteria Isolated From Healthy Ethiopian Infants","volume":"65","author":"Birri","year":"2013","journal-title":"Microb Ecol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00132","article-title":"Genomic Characterization of Dairy Associated Leuconostoc Species and Diversity of Leuconostocs in Undefined Mixed Mesophilic Starter Cultures","volume":"8","author":"Frantzen","year":"2017","journal-title":"Front Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: A Flexible Trimmer for Illumina Sequence Data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: A New Genome Assembly Algorithm and its Applications to Single-Cell Sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu153","article-title":"Prokka: Rapid Prokaryotic Genome Annotation","volume":"30","author":"Seemann","year":"2014","journal-title":"Bioinformatics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bti553","article-title":"ACT: The Artemis Comparison Tool","volume":"21","author":"Carver","year":"2005","journal-title":"Bioinformatics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr039","article-title":"Easyfig: A Genome Comparison Visualizer","volume":"27","author":"Sullivan","year":"2011","journal-title":"Bioinformatics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.43.1.140-143.2005","article-title":"Synergy Tests by E Test and Checkerboard Methods of Antimicrobial Combinations Against Brucella Melitensis","volume":"43","author":"Orhan","year":"2005","journal-title":"J Clin Microbiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/11.5.427","article-title":"The Fractional Inhibitory Concentration (FIC) Index as a Measure of Synergy","volume":"11","author":"Hall","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0168-1605(01)00560-8","article-title":"Bacteriocins: Safe, Natural Antimicrobials for Food Preservation","volume":"71","author":"Cleveland","year":"2001","journal-title":"Int J Food Microbiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/jb.02243-14","article-title":"Characterization of a Novel Plasmid-Borne Thiopeptide Gene Cluster in Staphylococcus Epidermidis Strain 115","volume":"196","author":"Bennallack","year":"2014","journal-title":"J Bacteriol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-9525(00)02024-2","article-title":"EMBOSS: The European Molecular Biology Open Software Suite","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900008106","article-title":"Thirteen Posttranslational Modifications Convert a 14-Residue Peptide Into the Antibiotic Thiocillin","volume":"106","author":"Wieland Brown","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00396-16","article-title":"Reconstitution and Minimization of a Micrococcin Biosynthetic Pathway in Bacillus subtilis","volume":"198","author":"Bennallack","year":"2016","journal-title":"J Bacteriol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00741-10","article-title":"Production of a New Thiopeptide Antibiotic, TP-1161, by a Marine Nocardiopsis Species","volume":"76","author":"Engelhardt","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1021\/ja909317n","article-title":"Molecular Determinants of Microbial Resistance to Thiopeptide Antibiotics","volume":"132","author":"Baumann","year":"2010","journal-title":"J\u00a0Am Chem Soc"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00829-20","article-title":"Successful Development of Bacteriocins Into Therapeutic Formulation for Treatment of MRSA Skin Infection in a Murine Model","volume":"64","author":"Ovchinnikov","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41522-020-00166-4","article-title":"A Bacteriocin-Based Antimicrobial Formulation to Effectively Disrupt the Cell Viability of Methicillin-Resistant Staphylococcus Aureus (MRSA) Biofilms","volume":"6","author":"Kranjec","year":"2020","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/08927014.2010.511200","article-title":"In Vitro and In Vivo Antibiofilm Activity of a Coral Associated Actinomycete Against Drug Resistant Staphylococcus Aureus Biofilms","volume":"26","author":"Bakkiyaraj","year":"2010","journal-title":"Biofouling"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10020131","article-title":"Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives","volume":"10","author":"Kranjec","year":"2021","journal-title":"Antibiot (Basel)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2174\/1381612824666180213121724","article-title":"Bacterial Luciferase Gene Cassette as a Real-Time Bioreporter for Infection Model and Drug Evaluation","volume":"24","author":"Wang","year":"2018","journal-title":"Curr Pharm Des"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.019695","article-title":"Fusidic Acid Resistance in Staphylococcus Aureus","volume":"89","author":"Dobie","year":"2004","journal-title":"Arch Dis Child"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-4310(00)01739-1","article-title":"Molecular Strategies for Overcoming Antibiotic Resistance in Bacteria","volume":"6","author":"Tan","year":"2000","journal-title":"Mol Med Today"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1002\/9783527676132","volume-title":"Novel Antimicrobial Agents and Strategies","author":"Phoenix","year":"2014"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41429-020-00387-x","article-title":"Thiopeptides: Antibiotics With Unique Chemical Structures and Diverse Biological Activities","volume":"74","author":"Chan","year":"2021","journal-title":"J Antibiot"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1039\/c8sc04885a","article-title":"Total Synthesis of Micrococcin P1 and Thiocillin I Enabled by Mo(vi) Catalyst","volume":"10","author":"Akasapu","year":"2019","journal-title":"Chem Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1021\/ja110166x","article-title":"Total Synthesis and Complete Structural Assignment of Thiocillin I","volume":"133","author":"Aulakh","year":"2011","journal-title":"J Am Chem Soc"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2014.107","article-title":"Resistance to Rifampicin: A Review","volume":"67","author":"Goldstein","year":"2014","journal-title":"J Antibiot"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2011.01030.x","article-title":"Selection of Antibiotics for Meticillin-Resistant Staphylococcus Pseudintermedius: Time to Revisit Some Old Drugs","volume":"23","author":"Papich","year":"2012","journal-title":"Vet Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive Use of Rifampin for the Treatment of Staphylococcus Aureus Infections: A Systematic Review of the Literature","volume":"168","author":"Perlroth","year":"2008","journal-title":"Arch Intern Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1086\/499365","article-title":"Dumb and Dumber\u2013The Potential Waste of a Useful Antistaphylococcal Agent: Emerging Fusidic Acid Resistance in Staphylococcus Aureus","volume":"42","author":"Howden","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/aac.35.12.2611","article-title":"Successful Therapy of Experimental Chronic Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus Aureus by Antimicrobial Combinations","volume":"35","author":"Chuard","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/s0305-4179(99)00045-5","article-title":"Rifampicin as an Adjunct to Vancomycin Therapy in MRSA Septicaemia in Burns","volume":"25","author":"Gang","year":"1999","journal-title":"Burns"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/aac.46.4.1122-1124.2002","article-title":"Combination of Quinupristin-Dalfopristin (Synercid) and Rifampin is Highly Synergistic in Experimental Staphylococcus Aureus Joint Prosthesis Infection","volume":"46","author":"Saleh-Mghir","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00702-13","article-title":"Vancomycin-Rifampin Combination Therapy has Enhanced Efficacy Against an Experimental Staphylococcus Aureus Prosthetic Joint Infection","volume":"57","author":"Niska","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00775-08","article-title":"Linezolid Alone or Combined With Rifampin Against Methicillin-Resistant Staphylococcus Aureus in Experimental Foreign-Body Infection","volume":"53","author":"Baldoni","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.072280-0","article-title":"Adjunctive Rifampicin May Improve Outcomes in Staphylococcus Aureus Bacteraemia: A Systematic Review","author":"Russell","year":"2014","journal-title":"J Med Microbiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/vde.12404","article-title":"Rifampicin Treatment of Canine Pyoderma Due to Multidrug-Resistant Meticillin-Resistant Staphylococci: A Retrospective Study of 32 Cases","volume":"28","author":"De Lucia","year":"2017","journal-title":"Vet Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)32456-x","article-title":"Adjunctive Rifampicin for Staphylococcus Aureus Bacteraemia (ARREST): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet (Lond Engl)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s15010-016-0874-2","article-title":"Should Daptomycin-Rifampin Combinations for MSSA\/MRSA Isolates be Avoided Because of Antagonism","volume":"44","author":"Stein","year":"2016","journal-title":"Infection"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10096-018-3393-5","article-title":"The Downside of Antimicrobial Agents for Wound Healing","volume":"38","author":"Punjataewakupt","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03106","article-title":"In Situ Treatment With Novel Microbiocide Inhibits Methicillin Resistant Staphylococcus Aureus in a Murine Wound Infection Model","volume":"10","author":"Hoffmann","year":"2019","journal-title":"Front Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.676534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T15:29:19Z","timestamp":1625239759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.676534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2021.676534"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.676534","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"article-number":"676534"}}